Trials / Conditions / Diabetes Mellitus, Adult-Onset

Diabetes Mellitus, Adult-Onset

15 registered clinical trials studyying Diabetes Mellitus, Adult-Onset — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Classification of Adult-onset Diabetes in Five Subgroups in Pakistani Population NCT06706609	Getz Pharma	—
Unknown	Oleocanthal Rich Olive Oil Acute Effects on Hyperglycemia and Platelet Activation in T2DM NCT04419948	Harokopio University	N/A
Terminated	Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients NCT02456051	University of Roma La Sapienza	—
Completed	Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and Blood NCT02650206	Stanford University	Phase 1
Completed	Tablet-Aided BehavioraL Intervention EffecT on Self-management Skills NCT02128854	Medical University of South Carolina	N/A
Completed	Technology Intensified Diabetes Education Study in African Americans NCT02088658	State University of New York at Buffalo	N/A
Terminated	Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation NCT01002339	Armando Torres Ramírez	Phase 4
Completed	Telephone Delivered Behavioral Skills Intervention for Blacks With T2DM NCT00929838	State University of New York at Buffalo	N/A
Completed	Effect of Cinnamon on Glucose and Lipid Levels in Non-Insulin Dependent Type 2 Diabetes Mellitus NCT00237640	University of Oklahoma	Phase 2
Completed	A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Manage NCT00231647	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 2
Terminated	A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on NCT00231634	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 3
Completed	A Study of the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Cont NCT00231530	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 3
Completed	A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated W NCT00231660	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 3
Completed	A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients W NCT00236626	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 2
Completed	Early Insulin Treatment in Patients With Latent Autoimmune Diabetes NCT01109927	Lund University Hospital	Phase 4